These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 17889166
1. Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors. San Segundo D, Fábrega E, López-Hoyos M, Pons F. Transplant Proc; 2007 Sep; 39(7):2290-2. PubMed ID: 17889166 [Abstract] [Full Text] [Related]
2. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients. Segundo DS, Ruiz JC, Izquierdo M, Fernández-Fresnedo G, Gómez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, López-Hoyos M, Arias M. Transplantation; 2006 Aug 27; 82(4):550-7. PubMed ID: 16926600 [Abstract] [Full Text] [Related]
3. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients. San Segundo D, Ruiz JC, Fernández-Fresnedo G, Izquierdo M, Gómez-Alamillo C, Cacho E, Benito MJ, Rodrigo E, Palomar R, López-Hoyos M, Arias M. Transplant Proc; 2006 Oct 27; 38(8):2391-3. PubMed ID: 17097943 [Abstract] [Full Text] [Related]
4. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Demirkiran A, Kok A, Kwekkeboom J, Kusters JG, Metselaar HJ, Tilanus HW, van der Laan LJ. Liver Transpl; 2006 Feb 27; 12(2):277-84. PubMed ID: 16447185 [Abstract] [Full Text] [Related]
5. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Calvo-Turrubiartes M, Romano-Moreno S, García-Hernández M, Chevaile-Ramos JA, Layseca-Espinosa E, González-Amaro R, Portales-Pérez D. Transpl Immunol; 2009 May 27; 21(1):43-9. PubMed ID: 19233271 [Abstract] [Full Text] [Related]
6. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. Korczak-Kowalska G, Wierzbicki P, Bocian K, Klosowska D, Niemczyk M, Wyzgal J, Korecka A, Durlik M, Chmura A, Paczek L, Górski A. Transplant Proc; 2007 Nov 27; 39(9):2721-3. PubMed ID: 18021968 [Abstract] [Full Text] [Related]
7. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, Robles R, Rios A, Aparicio P, Parrilla P. Transplantation; 2008 Nov 27; 86(10):1370-8. PubMed ID: 19034005 [Abstract] [Full Text] [Related]
8. Influence of immunosuppressive drugs on the development of CD4(+)CD25(high) Foxp3(+) T cells in liver transplant recipients. Chu Z, Zhang J, Zhao Y, Ji Q, Zhong J, Zhang C, Zhang B. Transplant Proc; 2010 Sep 27; 42(7):2599-601. PubMed ID: 20832552 [Abstract] [Full Text] [Related]
9. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients. Chu ZQ, Ji Q. Transplant Proc; 2013 Sep 27; 45(1):153-6. PubMed ID: 23375290 [Abstract] [Full Text] [Related]
10. Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. Codarri L, Vallotton L, Ciuffreda D, Venetz JP, Garcia M, Hadaya K, Buhler L, Rotman S, Pascual M, Pantaleo G. J Exp Med; 2007 Jul 09; 204(7):1533-41. PubMed ID: 17591854 [Abstract] [Full Text] [Related]
11. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation. van de Wetering J, Koumoutsakos P, Peeters A, van der Mast BJ, de Kuiper P, IJzermans JN, Weimar W, Baan CC. Clin Transplant; 2011 Jul 09; 25(1):40-6. PubMed ID: 20636406 [Abstract] [Full Text] [Related]
12. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant. Sakamoto R, Asonuma K, Zeledon Ramirez ME, Yoshimoto K, Nishimori A, Inomata Y. Exp Clin Transplant; 2009 Mar 09; 7(1):8-12. PubMed ID: 19364305 [Abstract] [Full Text] [Related]
13. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation. Wang Z, Xiao L, Shi BY, Qian YY, Bai HW, Chang JY, Cai M. Transpl Immunol; 2008 Apr 09; 19(1):69-73. PubMed ID: 18346640 [Abstract] [Full Text] [Related]
14. Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Stenard F, Nguyen C, Cox K, Kambham N, Umetsu DT, Krams SM, Esquivel CO, Martinez OM. Pediatr Transplant; 2009 Feb 09; 13(1):70-80. PubMed ID: 18331536 [Abstract] [Full Text] [Related]
15. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, Raimondi G, Thomson AW. Transplantation; 2008 Feb 15; 85(3):369-77. PubMed ID: 18301333 [Abstract] [Full Text] [Related]
16. CNI induced Th17/Treg imbalance and susceptibility to renal dysfunction in renal transplantation. Li Y, Shi Y, Huang Z, Bai Y, Niu Q, Cai B, Wang L, Feng W. Int Immunopharmacol; 2011 Dec 15; 11(12):2033-8. PubMed ID: 21911083 [Abstract] [Full Text] [Related]
17. Rapamycin promotes the expansion of CD4(+) Foxp3(+) regulatory T cells after liver transplantation. Lu L, Qian XF, Rao JH, Wang XH, Zheng SG, Zhang F. Transplant Proc; 2010 Jun 15; 42(5):1755-7. PubMed ID: 20620516 [Abstract] [Full Text] [Related]
18. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB. Transpl Immunol; 2008 Nov 15; 20(1-2):3-5. PubMed ID: 18773959 [Abstract] [Full Text] [Related]
19. Regulatory T cells contribute to the immunoregulatory effect on graft versus host reaction after liver transplantation in donor-dominant one-way MHC matching rats. Xue F, Chen W, Wang X, Wang L, Xu G, Liang L, Bai X, Liang T. Transpl Immunol; 2009 Mar 15; 20(4):232-7. PubMed ID: 19041396 [Abstract] [Full Text] [Related]
20. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients. Akl A, Jones ND, Rogers N, Bakr MA, Mostafa A, El Shehawy el M, Ghoneim MA, Wood KJ. Transpl Int; 2008 Jan 15; 21(1):65-73. PubMed ID: 17887959 [Abstract] [Full Text] [Related] Page: [Next] [New Search]